Insuman Comb 50 Solostar (Insulin Human)

Insuman Comb 50 Solostar provides insulin therapy for diabetes management and related insulin deficiency conditions.

• Type 1 diabetes mellitus: supplies basal and prandial insulin to achieve glycemic control.
• Type 2 diabetes mellitus: used when oral agents are insufficient to meet target blood glucose levels.
• Insulin deficiency states: replaces endogenous insulin to maintain normal glucose metabolism.

• Insulin Human binds to insulin receptors on muscle, adipose and hepatic cells, activating intracellular signaling pathways that increase glucose transporter translocation, enhance glucose uptake, and suppress hepatic gluconeogenesis. This results in reduced blood glucose concentrations and promotes storage of glucose as glycogen.

Common Side Effects

• Hypoglycemia: low blood glucose episodes, especially if meals are missed.
• Injection site pain or erythema: mild discomfort at the injection site.
• Lipodystrophy: localized thickening or thinning of subcutaneous tissue.
• Weight gain: increase in body weight due to improved glucose utilization.
• Edema: mild swelling of extremities.
• Allergic skin reactions: rash or itching at the site.

Serious or Rare Side Effects

• Severe hypoglycemia leading to seizures or loss of consciousness.
• Anaphylactic reaction: rapid onset of breathing difficulty, swelling, or hives.
• Hypersensitivity with systemic symptoms such as fever or malaise.
• Insulin antibody syndrome: formation of antibodies that alter insulin action.
• Lipoatrophy: marked loss of subcutaneous fat at injection sites.
• Severe allergic reactions: including angioedema.

Insuman Comb 50 Solostar requires careful monitoring and individualized dosing.

• Renal impairment: adjust dose and monitor glucose closely.
• Hepatic dysfunction: consider reduced clearance and monitor for hypoglycemia.
• Pregnancy: use only if benefits outweigh potential risks; category unknown.
• Elderly patients: start with lower doses and titrate slowly.
• Concomitant beta‑blockers: may mask hypoglycemia symptoms, requiring vigilant glucose checks.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 50 Solostar can interact with several drug classes, affecting glucose control.

Major Interactions (Avoid)

• Concurrent use of other insulin products: risk of additive hypoglycemia.
• Meglitinides (e.g., repaglinide): increased hypoglycemia potential.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may blunt hypoglycemia warning signs.
• ACE inhibitors and ARBs: can potentiate insulin’s glucose‑lowering effect.
• Thiazide diuretics: may raise blood glucose, requiring dose adjustment.
• Alcohol: enhances insulin action and can precipitate hypoglycemia.
• Oral contraceptives: may alter insulin requirements.